Translational Development... (TDACU)
NASDAQ: TDACU
· Real-Time Price · USD
10.36
0.00 (0.00%)
At close: Aug 20, 2025, 3:59 PM
Translational Development Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q2 2022 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | May 31, 2022 |
Revenue | 223.85K | 223.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 162.47K | 162.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 61.38K | 61.38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -763.21K | -542.92K | -196.36K | -546.82K | -486.03K | -485.79K | -485.55K | -3.4K | -2.9K | -2.3K | -1.7K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 3.04M | 1.41M | -71.01K | -546.82K | -486.03K | -485.79K | -485.55K | -3.4K | -2.9K | -2.3K | -1.7K |
Net Income | 3.04M | 1.41M | -71.01K | -546.82K | -486.03K | -485.79K | -485.55K | -3.4K | -2.9K | -2.3K | -1.7K |
Selling & General & Admin | 763.21K | 542.92K | 196.36K | 546.82K | 486.03K | 485.79K | 485.55K | 3.4K | 2.9K | 2.3K | 1.7K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 763.21K | 542.92K | 196.36K | 546.82K | 486.03K | 485.79K | 485.55K | 3.4K | 2.9K | 2.3K | 1.7K |
Interest Expense | -124.54K | -124.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 763.21K | 542.92K | 196.36K | 546.82K | 486.03K | 485.79K | 485.55K | 3.4K | 2.9K | 2.3K | 1.7K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 17.25M | 4.05M | 4.05M | 4.05M | 4.05M | 4.05M | 4.05M | 4.07M | 4.07M | 4.07M | 3.76M |
Shares Outstanding (Diluted) | 17.25M | 4.05M | 4.05M | 4.05M | 4.05M | 4.05M | 4.05M | 4.05M | 4.05M | 4.05M | 3.75M |
EPS (Basic) | 0.42 | 0.35 | -0.02 | -0.14 | -0.12 | -0.12 | -0.12 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.42 | 0.35 | -0.02 | -0.14 | -0.12 | -0.12 | -0.12 | -0.00 | -0.00 | -0.00 | -0.00 |
EBITDA | -764.89K | -543.77K | -196.36K | -545.13K | -484.35K | -484.35K | -484.35K | -500 | n/a | n/a | n/a |
EBIT | -763.21K | -542.92K | -196.36K | -546.82K | -486.03K | -485.79K | -485.55K | -3.4K | -2.9K | -2.3K | -1.7K |
Depreciation & Amortization | -1.69K | -843 | n/a | 1.69K | 1.69K | 1.45K | 1.2K | 2.9K | 2.9K | 2.3K | 1.7K |